During the past decade, Szent Margit Rendelőintézet conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Szent Margit Rendelőintézet" are "Type 2 Diabetes" (3 trials), "Obesity" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Knee Osteoarthritis" (1 trials). Many other conditions were trialed in "Szent Margit Rendelőintézet" in a lesser frequency.

Most popular intervention types in "Szent Margit Rendelőintézet" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (4 trials), "Dulaglutide" (3 trials), "Insulin Degludec" (2 trials) and "LY3502970" (2 trials). Other intervention names were less common.

The vast majority of trials in "Szent Margit Rendelőintézet" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Szent Margit Rendelőintézet". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Szent Margit Rendelőintézet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szent Margit Rendelőintézet, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".